Rigel Pharmaceuticals, Inc., announced that it has entered into a definitive agreement to acquire the U.S. rights to GAVRETO from Blueprint Medicines Corporation. GAVRETO...
AbbVie Inc., and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology....
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Catalyst Clinical Research announces that Nik Morton, the company's president and COO, assumed its CEO role on 12 February 2024. Mr. Morton joined Catalyst as its...
